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Risk Assessment for Acid Aerosols
by Roy E. Albert*
My experience has involved a great deal of method-
ology development for carcinogen risk assessment in
the Environmental Protection Agency, but none for
acid aerosols. However, there are some insights from
carcinogen risk assessment that do apply to acid aero-
sols. The greatest need is to understand mechanisms of
action as the basis for characterizing dose response
relationships at low levels ofexposure.
Risk assessment is an orderly assembly of the evi-
dence with some agreed upon guidelines as to how to
make judgments about the nature (qualitative assess-
ment) and magnitude (quantitative assessment) of
health hazards. Risk assessment provides guidance for
regulation, but the impetus for regulation comes from
public pressure to remedy perceived health problems.
Risk assessment answers the question, What is the
problem? Risk management deals with the question of,
What are we going to do about it? Risk assessment can
be likened to describing to regulators the picture on a
jigsaw puzzle where many of the pieces are missing.
Plausible assumptions are used to fill in the gaps. The
larger the range of uncertainty, the more room for
personal or institutional bias. Individuals who have
very different institutional loyalties and pressures can
produce very different risk assessments for the same
material where large uncertainties exist. Risk assess-
ments for formaldehyde, as a carcinogen, is a case in
point: whether formaldehyde is described as extremely
hazardous or entirely safe depends on who does the
assessment.
Carcinogen risk assessment, both in terms of its
guidelines and also in terms of the assessment of
specific agents, has been an area of extreme contention.
The alternative to risk assessment is standard setting
by the use of the highest no-observable-effect level
(NOEL) with arbitrary safety factors. This has been
described as "Stone Age" toxicology, and, in my opin-
ion, has been a blight on the development of toxicology
as a science. For all its contentiousness, risk assessment
has had the beneficial result of forcing a clear distinc-
tion between what is known and what is not known
and laying bare the assumptions that are necessary to
the development of exposure standards. There is no
meaningful risk assessment without quantitation of
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the associated hazards. There is no quantitation with-
out dose-response relationships. Because of the uncer-
tainties in observable low level effects, there can be con-
fidence in the dose-response relationships only with an
understanding of mechanisms of action.
There are some sharp contrasts between carcinogens
and acid aerosols in terms of risk assessment and
management. In terms of the impetus to regulate, there
was overwhelming pressure beginning in the 1970s
for the control of environmental carcinogens. The lack
of progress in cancer treatment led to the National
Program for the Conquest of Cancer beginning in
1970. There was an explosive growth of the numbers of
chemicals that were being introduced by the chemical
industry into the environment, and increasing
numbers of chemicals were shown to be carcinogenic
in animal and epidemiological studies. Epidemiologic
evidence strongly supported a dominant role of envi-
ronmental factors in the causation of cancer. So there
was initially a very large impetus for the regulation of
carcinogens and, hence, the assessment of suspect car-
cinogens. In the case of acid aerosols, there is a smaller
impetus for regulation because acid aerosols are in part
regulated under the control of atmospheric particu-
lates.
The regulatory objective for carcinogens is to
diminish the tremendous load of cancer mortality as
the second leading cause of death. In the case of acid
aerosols, the regulatory objective is less pressing: to
eliminate mortality among the moribund from heart
and pulmonary disease and the prevention of acute
impairments of pulmonary function and acute res-
piratory infections.
Tthe regulatory strategy for carcinogens is involved
because of different Congressional laws at different
times. It ranges from the banning of carcinogenic
additives under the Delaney clause of the Food and
Drug Act; the use of a zero concentration as a target
under the Drinking Water Act; weighing risks and
benefits under the Federal Insecticide, Rodenticide and
Fungicide Act and the Toxic Substances Control Act;
and specifying excess cancer risk levels of 10-5 to 10-7
for lifetime exposure as a guide for state regulation of
carcinogenic water pollutants. The Clean Air Act, in
regard to acid aerosols, calls for zero risk with a mar-
gin of safety, although the EPA has made strenuous
efforts to ease this requirement.R. E. ALBERT
The dominant dose-response model used for car-
cinogen risk assessment is linear nonthreshold. By
contrast, it is generally assumed that there is a thres-
hold for acid aerosol effects, but the shape of the dose-
response curve is not established. In both cases, under-
standing of mechanisms that would provide the basis
for low dose-response modeling is limited; in both
cases, individual susceptibility is an important factor
in determining response to low levels of exposure. The
nature of the response is different with carcinogens
than acid aerosols. In the case of carcinogens, the
response is quantal. With decreasing dose, there is no
change in the severity (i.e., malignancy) of induced
tumors, but simply a reduction in the frequency. In
the case of acid aerosols, as is characteristic of most
toxicants, a decrease in dose results both in a decrease
in the severity of the response and in the proportion of
individuals showing responses; the effect fades away.
In the case of carcinogens, risk assessment is mostly
done on individual compounds or, in some cases, on
mixtures which result from single sources, for exam-
ple, diesel emissions. In the case of acid aerosols, the
situation is more complex because the effects of acid
aerosols appear to be modified by a variety of other
associated air pollutants. Hence, the biggest differences
between risk assessment for carcinogens and acid
aerosols is the immense drive for regulation resulting
in the acceptance of an extremely conservative non-
threshold dose-response model for carcinogens in con-
trast to a weaker drive for regulation with a threshold
dose-response pattern for acid aerosols.
The rest of my comments deal with the risk assess-
ment needs for acid aerosols. The first need is to get a
better definition of the end points of response to acid
aerosols. Mortality as an end point is straightforward,
as is the induction of an increased incidence of res-
piratory disease although the severity of the latter effect
at different levels might be an aspect that could be
looked at. Another aspect that needs clarification is the
meaning, in terms of pulmonary performance, of
small decrements in pulmonary function test results
as, for example, when children show a small decrement
in a FEV1 evaluation during a summer haze episode.
The most important area of uncertain end points is the
chronic effects of acid aerosols. What is the nature of
the structure and functional effects of long-term ex-
posures to acid aerosols, particularly in relationship to
the decrements of pulmonary function associated with
aging? Does acid aerosol exposure have a amplifying
effect on the carcinogenic action of other air pollutants
as has been demonstrated with sulfur dioxide in the
rat lung with concurrent exposure to benzopyrene?
And, if so, what is the nature of the dose-response rela-
tionship for such an effect?
As indicated earlier, dose-response relationships are
critical issues in quantitative risk assessment. Human
studies are useful in identifying the nature of the
effects and in providing limited information on dose
response. Animals generally provide a better definition
of dose-response but always with the uncertainty as to
the applicability for humans. The combination of
human, animal, cellular, and subcellular responses
provides information on dose-response mechanisms
that give an indication of the shape of the dose
response. When the shape is combined with bench-
mark responses in humans one can get a reasonable
quantitative model for risk assessment. The dearth of
mechanistic knowledge has been the bane of carcin-
ogen risk assessment. Holma's work reported that this
meeting, on the role of mucus in protecting against
acid aerosols, is a good start on obtaining a theoretical
understanding of dose-response mechanisms. But
there are a lot of unanswered questions, such as, What
is the thickness and rate of production of mucus at
various levels of the tracheobronchial tree? Is mucus
distributed uniformly over the surface of the tracheo-
bronchial mucosa in normal subjects? This is not the
case in individuals chronically exposed to cigarette
smoke and air pollutants who have patches bare of
mucus in regions of squamous metaplasia. This is a
problem very similar to that for formaldehyde where
the issue is whether, at low concentrations, the pene-
tration through the mucous layer is zero. Can a simi-
lar sort of analysis be extended to defense mechanisms
against acid particulates in the alveoli? Here, there is
no mucus. Does the liquid film on the surface of the
alveoli have buffering capacity, and if so, how much?
Is there a cellular exudate at the site of the acid particle
deposition which neutralizes the acidity? Does the acid
coating facilitate the penetration of such particles into
the interior of cells which then get neutralized? There
is some analogy here with the so-called hot particle
problem in the field of ionizing radiation, where the
problem is the nature and magnitude of the toxico-
logic effects of isolated radioactive particles that are
deposited in the lung both in terms of chronic damage
and cancer induction.
A better understanding of the mechanism of the
other end points forthe effects ofacid aerosols discussed
above such as increased mortality, acute bronchitis,
exacerbation of chronic obstructive pulmonary dis-
ease, and decreased pulmonary function would sig-
nificantly contribute to a better definition of dose-
response relationships to be used in quantitative risk
assessment.
A particular difficulty with the characterization of
dose-response for acid aerosols is that they do not exist
in isolation in the atmosphere, and, more importantly,
their effects are synergistic with other pollutants,
especially ozone. This raises mechanistic questions as
to the bases for the interactions and the need to define
dose-response relationships for acid aerosols in the
presence ofother atmospheric pollutants.
In summary, the most important needs for the risk
assessment of acid aerosols is a better definition of end
points, particularly chronic effects, and a better under-
standing of mechanisms of action as they throw light
on the nature of the dose-response relationships at low
levels ofexposure.
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